Ireland· IE-PA-EU/1/18/1296/001-002
Tegsedi 284 mg solution for injection in pre-filled syringe
A other nervous system drugs product containing inotersen, registered in Ireland by Akcea Therapeutics Ireland Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Inotersen is registered in 3 of 19 countries.
Countries holding a registration under ATC N07 (other nervous system drugs), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Inotersen · ATC N07
3 / 19 countries
- Finlandprice
- Ireland
- Netherlands
The record
At a glance
HPRA (Ireland)- Active substance
- INOTERSEN
- Manufacturer
- Akcea Therapeutics Ireland Ltd
- Country
- Ireland (IE)
- ATC code
- N07
- ATC class
- OTHER NERVOUS SYSTEM DRUGS
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/18/1296/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inotersen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceTEGSEDI 284 mg, solution injectable en seringue préremplieAKCEA THERAPEUTICS IRELAND (IRLANDE)
- SpainTEGSEDI 284 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAkcea Therapeutics Ireland Limited
- FinlandTegsediAkcea Therapeutics Ireland Ltd
- United KingdomTegsedi 284mg/1.5ml solution for injection pre-filled syringesSwedish Orphan Biovitrum Ltd
- IcelandTegsediAkcea Therapeutics Ireland Ltd
- NetherlandsTegsedi 189 mg/ml, oplossing voor injectie in voorgevulde spuitAkcea Therapeutics Ireland Ltd
- PolandTegsediAkcea Therapeutics Ireland Ltd.
- SwedenTegsedi 284 mg Injektionsvätska, lösning i förfylld sprutaAkcea Therapeutics Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tegsedi
- Liechtenstein · Tegsedi
- Norway · Tegsedi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d602c01b-686b-4bcc-b449-c75b80582cd8 GET /v1/drugs/d602c01b-686b-4bcc-b449-c75b80582cd8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"N07"
],
"strength": null,
"pa_number": "EU/1/18/1296/001-002",
"substances": [
"INOTERSEN"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "06/07/2018",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about inotersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.